@Contrary_Res

The best starting point for understanding private tech companies. Powered by @contrary. Subscribe to our newsletter below:

research.contrary.com/
Joined March 2022
  • Tweets2.5K
  • Following132
  • Followers15K
775Media

AI Benchmarks: Climbing the Wrong Hills

In 1975, Charles Goodhart, the Chief Adviser to the Bank of England, observed that when governments tried to regulate a set of financial assets, those assets stopped being reliable indicators of econo…

Article · @Contrary_Res
2
1
4
2,297

The Path Forward for Legal AI

AI applications for law are perhaps the most widely debated and deeply funded AI applications aside from software engineering. Law and coding share fundamental similarities that make the relevance to …

Article · @Contrary_Res
1
1
2
1,402

AI Polling: How Synthetic Surveys Could Predict Real Behavior

Humans are, famously, the only animals that experience separately the concepts of what they want and what they want to want, a concept described and popularized by philosopher Harry Frankfurt in Freed…

Article · @Contrary_Res
1
1
4
3,376

The Expanding Potential of Neuromodulation

Neuromodulation is one of a few neurotechnologies that have moved from the laboratory into routine clinical practice. As of July 2026, more than 250K people had received deep brain stimulation (DBS) i…

Article · @Contrary_Res
1
7
2,106

Breaking Down the Orbital Launch Market

As the cost of launching satellites into space becomes ever cheaper, consulting firms, think tanks, and equity researchers alike have speculated that the industry is approaching launch commoditization…

Article · @Contrary_Res
1
5
1,347

Are Prediction Markets Doomed to Fail?

In the last year, few industries have captured cultural, regulatory, and investor interest to the same degree as prediction markets. Platforms like Kalshi and Polymarket, which have millions of active…

Article · @Contrary_Res
6
4,608

Rare Diseases and the Platform Biotech Renaissance

For decades, developing treatments for rare diseases, which are medical conditions that affect fewer than 200K people at any given time, were viewed as one of the least attractive markets for pharmace…

Article · @Contrary_Res
2
4
18
10,613

The Anti-Aging Therapeutics Boom

In January 2026, the FDA cleared the first cell reprogramming therapeutic drug for human testing with the implicit goal of reversing aging. Specifically, the agency cleared ER-100, a therapy designed …

Article · @Contrary_Res
2
3
2
16
31,670

The American Missile Crisis

Recent global conflicts, from Russia and Ukraine to Iran and Israel, have seen a resurgent awareness of the frailty of US munitions stock, which has been drawn down by both direct and indirect involve…

Article · @Contrary_Res
4
9
5
39
29,967

The Virtual Cell Revolution

Alzheimer’s disease is one of the deadliest and costliest diseases on Earth. It kills hundreds of thousands of Americans every year, afflicts an estimated 11% of all Americans 65 and older in 2026 (…

Article · @Contrary_Res
2
3
2
20
13,218

Mapping the Shadow Grid

In September 1882, Thomas Edison opened Pearl Street Station in lower Manhattan, a coal-fired plant serving 85 customers within a one-square-mile radius. Prior to Pearl Street, every factory and build…

Article · @Contrary_Res
5
1
29
17,684

Restoring American Rare Earth Independence

In 1992, former Chinese chairman Deng Xiaoping said, “The Middle East has oil, China has rare earths.” Today, China controls most of the rare earth supply chain, from mining to manufacturing. This…

Article · @Contrary_Res
3
1
17
20,473
Load more